Cargando…
A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis
The first tenet of medicine, “primum non nocere” or “first, do no harm”, is not always compatible with oncological interventions e.g., chemotherapy, targeted therapy and radiation, since they commonly result in significant toxicities. One of the more frequent and serious treatment-induced toxicities...
Autores principales: | Oronsky, Bryan, Goyal, Sharad, Kim, Michelle M., Cabrales, Pedro, Lybeck, Michelle, Caroen, Scott, Oronsky, Neil, Burbano, Erica, Carter, Corey, Oronsky, Arnold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918142/ https://www.ncbi.nlm.nih.gov/pubmed/29698934 http://dx.doi.org/10.1016/j.tranon.2018.03.014 |
Ejemplares similares
-
Electrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management
por: Oronsky, Bryan, et al.
Publicado: (2017) -
Navigating the “No Man's Land” of TKI-Failed EGFR-Mutated Non–Small Cell Lung Cancer (NSCLC): A Review
por: Oronsky, Bryan, et al.
Publicado: (2017) -
The War on Cancer: A Military Perspective
por: Oronsky, Bryan, et al.
Publicado: (2015) -
Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man—PFS2: A Measure of Therapeutic Action-At-A-Distance
por: Oronsky, Bryan, et al.
Publicado: (2015) -
Brief report: RRx-001 is a c-Myc inhibitor that targets cancer stem cells
por: Oronsky, Bryan, et al.
Publicado: (2018)